Nigeria receives HIV prevention injection

The Federal Government on Wednesday confirmed the receipt of the HIV prevention injection known as Lenacapavir.

National coordinator of the National HIV, viral hepatitis and STDs control programme at the Federal Ministry of Health and Social Welfare, Dr Adebobola Bashorun, in a statement on Wednesday, said the arrival of LEN reflects Nigeria’s continued dedication to leveraging innovation and evidence-based interventions to accelerate progress toward epidemic control.

Bashorun said, “NASCP, in collaboration with partners and stakeholders, will work to ensure the safe introduction, strategic deployment, and effective integration of Lenacapavir into the national HIV prevention options.

“The rollout will support ongoing efforts to increase access to prevention services while reinforcing Nigeria’s broader HIV response.

“NASCP remains committed to advancing equitable access to HIV prevention, testing, treatment, and care services. The arrival of Long-Acting Injectable Lenacapavir is a clear demonstration of Nigeria’s resolve to scale up innovative solutions and strengthen the fight against HIV. Together, Nigeria moves closer to ending HIV as a public health threat.”

Lenacapavir is an injectable treatment administered twice yearly, offering a more convenient alternative to daily oral preventive medications.

The statement noted that the introduction of Lenacapavir for PrEP marks a significant step towards broadening the range of prevention choices available to individuals at risk of HIV infection.

“As a long-acting injectable option, LEN PrEP has the potential to improve adherence and expand access to effective HIV prevention services for populations that may face challenges with daily oral prevention options.

“By expanding prevention options and strengthening service delivery, the country is taking decisive steps to reduce new HIV infections and improve health outcomes for communities across Nigeria,” the statement further read.

The drug is expected to be available in Nigeria and 119 other low- and middle-income countries for $40 per person annually, following voluntary licensing agreements with generic manufacturers.

“This milestone, approved by the Coordinating Minister of Health and Social Welfare, Prof Ali Pate and supported through the Global Fund, represents a major advancement in the country’s HIV prevention efforts and further strengthens Nigeria’s commitment to expanding innovative HIV prevention options,” the statement further read.(Punch)